The Mate X6 has a 50MP variable aperture camera with a ten-size adjustable physical aperture, ranging from F1.0 to F4.0. The ...

Beleaguered Chinese tech giant Huawei made headlines in October for unveiling a new version of its smartphone operating system with no remaining ties to Android code, but HarmonyOS Next hasn’t made ...

In the wake of Keros Therapeutics Inc.’s voluntary halt of dosing in two arms of its phase II study of pulmonary arterial hypertension, the company’s stock (NASDAQ:KROS) has crumpled after a year’s ...

HUAWEI has launched its latest foldable, the Mate X6, in international markets alongside the Freebuds Pro 4 and the Nova 13 ...

The merger of Nvelop Therapeutics and Chroma Medicine brings together a combination of epigenetic editing and in vivo ...

The Institute of Cancer Research establishes spinout companies where this is the most appropriate route to patient benefit.

The new company has also raised $75 million that will support the development of epigenetic editing therapies for hepatitis B ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning, hope everyone is ...

Chroma Medicine and Nvelop Therapeutics today announced their merger and subsequent launch of nChroma Bio ("nChroma" or "the company") to redefine the future of genetic medicines. nChroma brings ...

The combined company, which will pair Chroma’s epigenetic editing with Nvelop’s non-viral particles, has raised $75 million ...

PLC ("TC BioPharm" or the "Company")  a clinical-stage biotechnology company developing platform allogeneic gamma-delta T cell therapies for cancer and other indications, today announced a partnership ...

In industry parlance, the deal joins a “delivery” company with a “cargo” company — fusing the two key pieces needed to build ...